美国临床医生对帕金森病早期使用脑深部电刺激的看法:一项定性研究
多数医生认为早期使用不仅取决于时间,更由患者症状决定;仅16.8%知晓FDA近期关于早期使用的适应证,25%不确定DBS是否应被视为早期治疗方式。神经科医生平均建议在诊断后6年、药物耗尽后考虑DBS。
要点
- 多数医生认为早期DBS使用取决于患者症状而非单纯时间。
- 仅16.8%受访者知晓FDA关于早期DBS使用的近期适应证。
- 神经科医生平均在诊断后6年、药物耗尽后建议DBS。
核心结论
- 临床医生对DBS转诊参数和时机存在广泛差异,需要更大规模研究验证。
主要发现
- 多数临床医生认为早期使用不仅取决于时间,更由患者症状决定。
- 仅16.8%受访者知晓FDA关于早期使用DBS的近期适应证。
- 25%受访者不确定DBS是否应被视为早期治疗方式。
- 神经科医生平均建议在药物耗尽后、通常诊断后6年将DBS作为下一步治疗选择。
临床怎么用
- 临床医生对早期DBS使用的时间参数和转诊标准存在广泛差异,需更多研究支持临床指南制定。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In November 2015, the U.S. Food and Drug Administration (FDA) approved the use of deep brain stimulation (DBS) therapy in people with Parkinson's disease (PD) "of at least four years duration and with a recent onset of motor complications, or motor complications of longer-standing duration that are not adequately controlled with medication." Although the full implications of this more recent approval are yet to be determined, to date, there are no strict criteria defining appropriate earlier use of DBS. As such, confusion remains regarding the actual meaning of early DBS initiation. To better inform responsive policy, we sought the perspectives of movement disorder neurologists and neurosurgeons regarding the earlier use of DBS. Insights from these clinicians are key to developing appropriate clinical guidelines and determining how early is too early. The objective of this study is to explore attitudes among clinicians toward the earlier use of DBS for PD. METHODS: Twelve Michigan-based clinicians were interviewed both about DBS referral/use processes and their perspectives regarding the earlier use of DBS in PD. We used a structured interview with closed- and open-ended questions. All interviews were transcribed verbatim and analyzed using a mixed-method approach. RESULTS: We found that most clinicians considered earlier use not solely to be time dependent but instead determined by patient symptoms. Only 16.8% were aware of the FDA's recent indication of early use of DBS, with 25% of our respondents being unsure as to whether it should be seen as an early treatment modality. On average, neurologists suggested DBS as the next treatment option, after medications have been exhausted, typically 6 years after diagnosis. CONCLUSIONS: There remain wide variations in terms of clinicians' parameters for referrals and timing of DBS. Larger studies are needed to support or refute our findings.
引用
- Cabrera LY, Sarva H, Sidiropoulos C, et al. Perspectives on the Earlier Use of Deep Brain Stimulation for Parkinson Disease from a Qualitative Study of U.S. Clinicians. World Neurosurg. 2019. PMID: 30880198. doi:10.1016/j.wneu.2019.03.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。